Giulia Odorici

Ferrara, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 73 publications

Real-life experience of tildrakizumab 200 mg in complex psoriatic patients: a case series.

Real-life experience of tildrakizumab 200 mg in complex psoriatic patients: a case series.

Journal: Frontiers in medicine

Published: January 15, 2026

Rapid control of chronic spontaneous urticaria with dupilumab in a patient with severe atopic dermatitis.

Rapid control of chronic spontaneous urticaria with dupilumab in a patient with severe atopic dermatitis.

Journal: Italian journal of dermatology and venereology

Published: September 18, 2025

Switching to brodalumab after failure of IL-17A inhibitors in psoriatic patients: A real-life multicentre study.

Switching to brodalumab after failure of IL-17A inhibitors in psoriatic patients: A real-life multicentre study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: April 22, 2025

TNF-alpha inhibitors reduce the incidence of PsA in patients with psoriasis: a propensity score-matched cohort study.

TNF-alpha inhibitors reduce the incidence of PsA in patients with psoriasis: a propensity score-matched cohort study.

Journal: Rheumatology (Oxford, England)

Published: March 24, 2025

Effectiveness of Tildrakizumab 200 mg in Moderate-to-Severe Plaque Psoriasis: A Multicenter Real-World Study Analyzing Patient Outcomes by Weight, PASI, BMI, and Previous Therapies.

Effectiveness of Tildrakizumab 200 mg in Moderate-to-Severe Plaque Psoriasis: A Multicenter Real-World Study Analyzing Patient Outcomes by Weight, PASI, BMI, and Previous Therapies.

Journal: Dermatology and therapy

Published: March 02, 2025

Radiation-induced angiosarcoma of the breast: an uncommon polymorphic disorder.

Radiation-induced angiosarcoma of the breast: an uncommon polymorphic disorder.

Journal: Italian journal of dermatology and venereology

Published: June 17, 2024

Real Life Comparative Effectiveness of IL-23 Inhibitors in the Treatment of Moderate to Severe Psoriasis: A Multicenter Experience.

Real Life Comparative Effectiveness of IL-23 Inhibitors in the Treatment of Moderate to Severe Psoriasis: A Multicenter Experience.

Journal: Dermatology practical & conceptual

Published: March 25, 2024

Psoriasis with Leg Involvement as the New Difficult-To-Treat Area: A Cohort Study of Patients Treated With Risankizumab.

Psoriasis with Leg Involvement as the New Difficult-To-Treat Area: A Cohort Study of Patients Treated With Risankizumab.

Journal: Dermatology practical & conceptual

Published: March 03, 2024

PsoBioVax: A multicentric Italian case-control study of the immunological response to anti-SARS-CoV-2 vaccine among psoriatic patients under biological therapy.

PsoBioVax: A multicentric Italian case-control study of the immunological response to anti-SARS-CoV-2 vaccine among psoriatic patients under biological therapy.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: June 27, 2023

Dietary habits of psoriatic patients treated with dimethyl fumarate and drug-related side effects: results from an observational study.

Dietary habits of psoriatic patients treated with dimethyl fumarate and drug-related side effects: results from an observational study.

Journal: Italian journal of dermatology and venereology

Published: March 20, 2023

Behandlung des Netherton-Syndroms mit Dupilumab.

Behandlung des Netherton-Syndroms mit Dupilumab.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: December 12, 2022

Treatment of Netherton syndrome with dupilumab.

Treatment of Netherton syndrome with dupilumab.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: November 02, 2022

Showing 1-12 of 73

Last Updated: 09/26/2026